PMO & ASO Therapeutics
Morpholino monomers, modified nucleosides, and specialty reagents for oligonucleotide discovery.
Applications
Application areas across modern therapeutic modalities
The product and service structure maps directly to current discovery needs in oligonucleotide, delivery, degrader, and peptide programs.
mRNA, siRNA & Gene Therapy
LNP lipid materials and delivery-focused chemistry for nucleic acid formulation programs.
Targeted Protein Degradation
PROTAC linkers, E3 ligand derivatives, and complex intermediates for degrader discovery.
Peptide Drug Discovery
Protected amino acids, unnatural amino acids, and custom peptide building blocks.
Search Strategy